The FDA's decision is a win for vaccine makers Pfizer, Moderna and Novavax, which have all been developing versions of their Covid shots to target XBB.1.5.
XBB.1.5 accounted for nearly 40% of all Covid cases in the U.S. in early June, according to
That panel unanimously voted that new jabs should be monovalent and target a member of the XBB family. Advisors also generally agreed that targeting XBB.1.5 would be the most ideal option.The three companies have already been developing updated versions of their shots that target XBB.1.5. Preliminary data each company presented on Thursday suggests that those jabs produce strong immune responses against all XBB variants.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
FDA advisors recommend that new Covid vaccines target an omicron XBB variant this fallThe FDA advisory panel's recommendation is a win for Covid vaccine makers Pfizer, Moderna and Novavax, which will race to deliver updated shots for the fall.
Weiterlesen »
U.S. to Target XBB Strain When Covid Shots Roll Out This FallCovid-19 shots administered this fall should target the latest offshoots of Omicron now circulating in the U.S., advisers to the Food and Drug Administration said
Weiterlesen »
The COVID-19 Vaccine Is Likely Getting an UpdateNew COVID-19 shots for the fall will probably target an XBB strain.
Weiterlesen »
FDA advisors raise doubts about seasonal updates to Covid vaccines as with flu shotsThe panel's concerns push back against the FDA's proposed shift to annual Covid shots — an approach that vaccine makers like Pfizer are already preparing for.
Weiterlesen »
FDA advisers consider changing COVID vaccine to target latest omicron strainThe COVID-19 vaccines are on track for a big recipe change this fall
Weiterlesen »
FDA Advisers Meet to Decide Next COVID Booster ShotXBB 1.5 is the dominant strain now circulating, with 40% of new cases having this strain, according to the U.S. Centers for Disease Control and Prevention. About 18% of new cases have XBB.1.16 and 12.5% have XBB 1.9.1.
Weiterlesen »